©The Author(s) 2026.
World J Hepatol. Feb 27, 2026; 18(2): 113004
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.113004
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.113004
Table 3 Linear trend analysis of lymphocyte subsets and their percentages in association with the time to negative severe acute respiratory syndrome coronavirus 2 nucleic acid test result in patients with coronavirus disease 2019 and non-alcoholic fatty liver disease
| Variable | F | P value |
| LY (cells/μL) | 53.817 | < 0.001 |
| LY% | 27.065 | < 0.001 |
| CD3+ (cells/μL) | 54.778 | < 0.001 |
| CD3+CD4+ (cells/μL) | 50.838 | < 0.001 |
| CD3+CD8+ (cells/μL) | 29.331 | < 0.001 |
| CD3+% | 3.251 | 0.072 |
| CD3+CD4+% | 0.003 | 0.955 |
| CD3+CD8+% | 0.001 | 0.972 |
| CD4/CD8 | 0.459 | 0.499 |
| CD19+ (cells/μL) | 8.599 | 0.008 |
| CD56+ (cells/μL) | 3.501 | 0.076 |
| CD19+% | 1.673 | 0.211 |
| CD56+% | 0.114 | 0.739 |
- Citation: Yan P, Li R, Yuan XY, Wang Y, Lan LJ, Yu XP, Liu DF. Dynamic immune response and its influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study. World J Hepatol 2026; 18(2): 113004
- URL: https://www.wjgnet.com/1948-5182/full/v18/i2/113004.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i2.113004